Stock 600332 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
31.55 CNY +0.03% Intraday chart for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited +7.39% +10.31%
Mar. 15 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 01 Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug MT

Business Summary

Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.

Number of employees: 28,048

Sales per Business

HKD in Million2022Weight2023Weight Delta
Big Business
70.0 %
57,315 69.6 % 58,448 70.0 % +1.98%
Great Health
14.7 %
12,199 14.8 % 12,300 14.7 % +0.83%
Great Southern Medicine
14.5 %
12,242 14.9 % 12,124 14.5 % -0.96%
Other
0.7 %
562 0.7 % 572 0.7 % +1.66%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.5 %
82,286 100.0 % 83,064 99.5 % +0.95%
Other Countries
0.5 %
32 0.0 % 380 0.5 % +1,089.00%

Managers

Managers TitleAgeSince
Hong Li CEO
 Chief Executive Officer 57 17-06-22
Rui Yu Cai CHM
 Chairman 57 -
Chun Bo Zhang BRD
 Director/Board Member 47 14-12-31
Chang Hai Wu BRD
 Director/Board Member 58 10-06-27
Hao Shan Zheng PRN
 Corporate Officer/Principal 48 -
Jian Xiong Zheng PRN
 Corporate Officer/Principal 54 -
Xue Zhen Huang SEC
 Corporate Secretary 50 17-04-25

Members of the board

Members of the board TitleAgeSince
Lung Tak Wong BRD
 Director/Board Member 76 10-06-27
Ju Yan Liu BRD
 Director/Board Member 59 13-11-30
Hong Li CEO
 Chief Executive Officer 57 17-06-22
Chun Bo Zhang BRD
 Director/Board Member 47 14-12-31
Rui Yu Cai CHM
 Chairman 57 -
Jin Yuan Cheng BRD
 Director/Board Member 51 20-01-12
Ya Jin Chen BRD
 Director/Board Member 61 20-06-28
Min Huang BRD
 Director/Board Member 60 20-06-28
Hui Dong Jian BRD
 Director/Board Member 51 21-06-02
Bao Qing Sun BRD
 Director/Board Member 53 23-05-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,405,890,949 582,176,011 ( 41.41 %) 0 49.33 %
Stock B 1 219,900,000 219,900,000 ( 100.00 %) 0

Shareholders

NameEquities%Valuation
Norges Bank Investment Management
16.04 %
35,281,000 16.04 % 87 M ¥
LSV Asset Management
5.996 %
13,186,111 5.996 % 32 M ¥
HBM Partners AG (Investment Management)
1.186 %
2,609,000 1.186 % 6 M ¥
MC China Ltd. (Investment Management)
0.5984 %
1,315,986 0.5984 % 3 M ¥
China Merchants Fund Management Co., Ltd.
0.2711 %
596,193 0.2711 % 1 M ¥
State Street Global Advisors Ltd.
0.2275 %
500,209 0.2275 % 1 M ¥
Generali Investments LLC
0.1594 %
350,548 0.1594 % 861 763 ¥
Focusbridge Investments Ltd.
0.1592 %
350,000 0.1592 % 860 416 ¥
AXA Investment Managers Asia (Singapore) Ltd.
0.1382 %
304,000 0.1382 % 747 332 ¥
LähiTapiola Varainhoito Oy
0.0937 %
206,000 0.0937 % 506 416 ¥
NameEquities%Valuation
Guangzhou State-Owned Assets Supervision & Admin. Commission
53.43 %
751,138,850 53.43 % 2 998 M ¥
Guangzhou Chengfa Investment Capital Management Co. Ltd.
5.215 %
73,313,783 5.215 % 293 M ¥
China Securities Finance Corp. Ltd.
3.363 %
47,277,962 3.363 % 189 M ¥
China Southern Asset Management Co., Ltd.
0.6187 %
8,698,464 0.6187 % 35 M ¥
Zhong Ou Asset Management Co., Ltd
0.5533 %
7,778,270 0.5533 % 31 M ¥
Hongde Fund Management Co., Ltd.
0.5126 %
7,206,353 0.5126 % 29 M ¥
China Asset Management Co., Ltd.
0.4664 %
6,557,417 0.4664 % 26 M ¥
GF Fund Management Co., Ltd.
0.2462 %
3,461,213 0.2462 % 14 M ¥
Rongtong Fund Management Co., Ltd.
0.2382 %
3,348,923 0.2382 % 13 M ¥
Fullgoal Fund Management Co., Ltd.
0.2309 %
3,246,348 0.2309 % 13 M ¥

Holdings

NameEquities%Valuation
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
7.72%
 30,880,304 7.72% 81,522,150 $
C.Q. PHARMACEUTICAL HOLDING CO., LTD.
1.50%
 25,992,330 1.50% 18,736,831 $
CHARMACY PHARMACEUTICAL CO., LTD.
1.00%
 1,080,000 1.00% 1,435,136 $

Company contact information

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

No. 45 Sha Mian North Street Liwan District

510130, Guangzhou

+86 20 6628 1011

http://www.gybys.com.cn
address Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
19 CNY
Average target price
22.06 CNY
Spread / Average Target
+16.14%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.91% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.09% 215B
NOVARTIS AG Stock Novartis AG
+8.08% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.22% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 874 Stock
  4. 600332 Stock
  5. Company Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited